RxDoctor Payments Data

Owen Meyers, MD

Family Medicine · Monroe, LANPI 1770597668

Payments from drug & device makers

$1,299in general payments, 2019–2025

Across 63 payments — averaging $20.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$238
  • GSK$226
  • AstraZeneca$165
  • Bayer$109
  • Novo Nordisk$85
  • Abbott$84
  • plus $393 from 11 others

What the payments were for

  • Food & beverage$1,299100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,299 in reported general payments places this provider in the 60th percentile of 1,469 family medicine providers in Louisiana.

See all family medicine providers in Louisiana

Medicare billing

Part B allowed, 2024
$238,814
Medicare patients
471
Services billed
5,917

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban148$108,838
OzempicSemaglutide93$94,175
JardianceEmpagliflozin48$48,059
RybelsusSemaglutide20$27,120
XareltoRivaroxaban23$23,222
MounjaroTirzepatide23$22,518
Trelegy ElliptaFluticasone/Umeclidin/Vilanter23$16,860
TrulicityDulaglutide13$15,404
FarxigaDapagliflozin Propanediol11$14,591
Janumet XrSitagliptin Phos/Metformin Hcl17$13,340
Lantus SolostarInsulin Glargine,hum.Rec.Anlog108$11,960
Pantoprazole Sodium471$9,218
Breo ElliptaFluticasone/Vilanterol12$7,188
Atorvastatin Calcium493$7,061
Gabapentin312$7,057

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$85$121,295113 claims
PfizerEliquis, Premarin$238$112,622161 claims
Boehringer IngelheimJardiance$19$48,05948 claims
Lilly USA, LLCMounjaro, Trulicity$52$37,92236 claims
GSKTrelegy Ellipta, Breo Ellipta$226$24,04835 claims
AstraZenecaFarxiga$165$14,59111 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 1,469 family medicine providers in Louisiana.

Other family medicine in Monroe

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →